By MATTHEW PERRONE
WASHINGTON (AP) — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases.
Related Articles
‘Come and take it’: Massachusetts governor challenges RFK Jr.’s request for Dunkin’, Starbucks ingredients Kennedy Center exodus continues as National Symphony director Jean Davidson heads to the Wallis Judge weighs bid to block policy limiting journalists’ access to Pentagon US issues a license that authorizes sales of Venezuelan gold Evidence suggests the deadly blast at an Iranian school was likely a US airstrikeFDA Commissioner Marty Makary announced the news to FDA staff in an email late Friday, saying Prasad would depart at the end of April. Makary said Prasad would return to his academic job at the University of California, San Francisco.
Prasad’s latest ouster follows a string of high-profile controversies involving the FDA’s review of vaccines, gene therapies and biotech drugs in which companies have criticized the agency for reversing itself, in some cases calling for new trials of products previously greenlighted by regulators.
In July, Prasad was briefly forced from his job after running afoul of biotech executives, patient groups and conservative allies of President Donald Trump. He was reinstated less than two weeks later with the backing of Health Secretary Robert F. Kennedy Jr. and Makary.
A longtime academic and critic of the FDA’s standards for drug reviews, Prasad has taken a seemingly contradictory approach to regulation since arriving at the FDA last May. On repeated occasions, Prasad has joined Makary in announcing steps to make FDA drug reviews faster and easier for companies. But he also has imposed new warnings and study requirements for some biotech drugs and vaccines, particularly COVID shots that have long been a target for Kennedy, a longtime anti-vaccine activist before joining the Trump administration.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hence then, the article about trump administration s embattled fda vaccine chief is leaving for the second time was published today ( ) and is available on Los Angeles Daily News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Trump administration’s embattled FDA vaccine chief is leaving for the second time )
Also on site :
- Warning Issued as Thousands Told to Stay Inside for 37 Hours
- Watch the N.H. Liquor & Wine Outlet video that’s lowkey going viral
- Coalition Of Public Interest Groups Call For State Attorneys General To Challenge Paramount-Warner Bros. Discovery Merger